Anixa Biosciences, Inc. (ANIX)

Anixa Biosciences Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Year Ending	TTM	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019
Cash & Equivalents	1	0.92	12.36	29.13	6.42	3.49
Short-Term Investments	22.24	22.93	17.33	6.6	2.64	2.35
Cash & Cash Equivalents	23.24	23.84	29.69	35.73	9.06	5.84
Cash Growth	-13.85%	-19.68%	-16.91%	294.47%	55.04%	15.54%
Receivables	0.22	0.27	0.05	0	0	0.07
Other Current Assets	0.76	1.24	0.47	0.28	0.31	0.18
Total Current Assets	24.21	25.36	30.2	36	9.37	6.09
Property, Plant & Equipment	0.14	0.17	0.21	0.25	0.05	0.2
Other Long-Term Assets	0	0	0	0	0.03	0
Total Long-Term Assets	0.14	0.17	0.21	0.25	0.08	0.2
Total Assets	24.36	25.52	30.41	36.26	9.45	6.29
Accounts Payable	0.22	0.21	0.27	0.14	0.23	0.59
Current Debt	0.06	0.05	0.05	0.04	0.06	0
Other Current Liabilities	1.41	1.77	1.73	1.1	0.9	0.9
Total Current Liabilities	1.68	2.03	2.04	1.27	1.19	1.48
Long-Term Debt	0.09	0.12	0.18	0.22	0	0
Total Long-Term Liabilities	0.09	0.12	0.18	0.22	0	0
Total Liabilities	1.77	2.15	2.21	1.49	1.19	1.48
Total Debt	0.15	0.18	0.22	0.26	0.06	0
Debt Growth	-24.75%	-20.81%	-14.67%	369.22%	-	-
Retained Earnings	-234.59	-228.2	-218.39	-204.79	-191.84	-181.82
Shareholders' Equity	23.62	24.34	29.05	35.44	8.76	5.24
Net Cash / Debt	23.09	23.67	29.47	35.47	9	5.84
Net Cash / Debt Growth	-13.77%	-19.67%	-16.92%	294.01%	54.10%	15.54%
Net Cash Per Share	0.72	0.76	0.97	1.24	0.40	0.30
Working Capital	22.53	23.33	28.16	34.73	8.18	4.61
Book Value Per Share	0.74	0.79	0.96	1.24	0.39	0.27

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).